RE:The money situationHe had five years as director of biz development or some designation like that. Maybe he tried to get other funding, but did he REALLY try hard enough knowing he would lose some control once he's back as CEO? We'll never know. Here we are, in desperation mode for a company whose data knocks the socks off other approved drugs. Very hard to believe. They say it's darkest before the dawn, but the sun ain't been shining for a long time. Hoping for a fantastic sunrise this quarter. Let's start with a pre-BTD submission update by end January.
DJDawg wrote: I share others worry about the money situation. In hindsight it is so obvious that the LIFE would fail once the news of it was release. Every financing round has dropped the price. There are not a ton of people that would see it as being a deal to buy shares at 0.22 when the market will sell them to you at 0.17. It speaks to the craziness of TLT that the price could drop that far on news like that.
It is a good wakeup call to RDW that he needs to be hungrier to find a funding source. I suspect that the main reason for no money from those sources is his rigid control of the company. I have a hard time believing that he was trying to find finding sources for all those years. How can you not find a funding source if you were showing that data to enough people. I don't really think he was trying till recently. I think he was coasting on the cash they had and confident that the warrants would help him.
I really hope that his current judgement is not all based on the idea that BTD will solve all his problems. That would be nuts.
I really hope that they can make some announcements on the patient updates when they come in as they need those PR bumps.
If they can announce something meaningful about GBM then they would become a company with two pipelines which would be far stronger and more appealing.